Stonebridge Financial Group (Pennsylvania)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.23M Buy
54,010
+8,397
+18% +$677K 0.32% 80
2026
Q1
$3.95M Buy
45,613
+2,108
+5% +$202K 0.33% 79
2025
Q4
$4.18M Buy
43,505
+1,719
+4% +$167K 0.36% 77
2025
Q3
$3.98M Buy
41,786
+699
+2% +$64.3K 0.35% 79
2025
Q2
$3.58M Buy
41,087
+1,594
+4% +$135K 0.35% 79
2025
Q1
$3.55M Buy
39,493
+8,973
+29% +$803K 0.38% 73
2024
Q4
$2.44M Buy
+30,520
New +$2.64M 0.27% 81

Other funds holding MDT

Stonebridge Financial Group (Pennsylvania)'s MDT Position: Q2 2026 in Review

Stonebridge Financial Group (Pennsylvania) increased its Medtronic (MDT) stake by 18% in Q2 2026, buying an estimated $677K and bringing the position to 54,010 shares worth $4.23M. The position accounts for 0.32% of the portfolio, ranked #80.

Stonebridge Financial Group (Pennsylvania) first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. 1,806 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Stonebridge Financial Group (Pennsylvania) held 54,010 shares of Medtronic worth $4.23M as of Q2 2026.
  • Stonebridge Financial Group (Pennsylvania) bought 8,397 Medtronic shares in Q2 2026, an estimated $677K.
  • Medtronic made up 0.32% of Stonebridge Financial Group (Pennsylvania)'s portfolio in Q2 2026, its #80 holding.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • 1,806 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2026, filed 6 Jul 2026.